drugset / Trial / NCT01086150
Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
Phase 2/3
Completed
51 enrolled
Albany Medical College
Endo USA Inc., a Keenova Therapeutics Company · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if an investigational drug known as the lidocaine 5% patch is safe and effective in reducing the symptoms of diabetic neuropathy, to examine how topical lidocaine affects the nerve endings, and to determine whether treatment with the lidocaine patch can prevent the potential progression to chronic diabetic neuropathy pain in subjects who did not report pain at the start of the study.
Timeline
- Start
- 2009-10
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 5 % | — |